latest news on glp 1 Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan FDA approves Eli Lilly's GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Zhang M, Lin Q, Qi T, Wang T, Chen CC, Riggs AD, Zeng D

The sustained weight loss in Amgen's study appears to contrast with results seen in clinical trials on Zepbound and Wegovy

Contact your healthcare provider if you experience severe abdominal pain, no bowel movement for more than three days despite using laxatives, rectal bleeding, persistent vomiting, or fever

All data were analyzed using GraphPad Prism software (version 10.0.3

Most patients continue to experience sustained reductions in food intake and feelings of satiety, though individual responses vary and the effect may be less intense than during initial treatment